(Boursier.com) — DBV Technologiesa clinical-stage biopharmaceutical company, announced that Daniel Tassé, Chief Executive Officer, will be presenting at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18 at 2:40 p.m. CET (8:40 a.m. ET).
A webcast of the presentation will be available in the Investors and Media section of the Company’s website: https://www.dbv-technologies.com/investor-relations/
A replay of the presentation will also be available on the DBV Technologies website after the event.
©2022 Boursier.com